We have shown previously that the Rhesus (Rh) polypeptides are the com
monest targets for pathogenic anti-red blood cell (RBC) autoantibodies
in patients with autoimmune hemolytic anemia (AIHA). The aim of the c
urrent work was to determine whether activated T cells from such patie
nts also mount recall responses to epitopes on these proteins. Two pan
els of overlapping 15-mer peptides, corresponding to the sequences of
the 30-kD ph proteins associated with expression of the D and Cc/Ee bl
ood group antigens, were synthesized and screened for the ability to s
timulate the in vitro proliferation of mononuclear cells from the peri
pheral blood or spleen of nine AIHA cases. Culture conditions were cho
sen that favor recall proliferation by previously activated T cells, r
ather than primary responses. In seven of the patients, including all
four cases with autoantibody to the ph proteins, two or more peptides
elicited proliferation, but cells from eight of nine patients with oth
er anemias and seven of nine healthy donors failed to respond to the p
anels. Multiple peptides were also stimulatory in two positive control
donors who had been alloimmunized with ph D-positive RBCs. Six differ
ent profiles of peptides elicited responses in the AIHA patients, and
this variation may reflect the different HLA types in the group. Stimu
latory peptides were identified throughout domains shared between, or
specific to, each of the related 30-kD Rh proteins, but T cells that r
esponded to nonconserved regions did not crossreact with the alternati
ve sequences. Anti-major histocompatibility complex class tl antibodie
s blocked the responses and depletion experiments confirmed that the p
roliferating mononuclear cells were T cells. Notably, splenic T cells
that proliferated against multiple Rh peptides also responded to intac
t RBCs. We propose that pathogenic autoantibody production in many cas
es of AIHA is driven by the activation of T-helper cells specific for
previously cryptic epitopes on the Rh proteins. (C) 1997 by The Americ
an Society of Hematology.